Skip to main content
All lobbying filings

BGR GOVERNMENT AFFAIRS

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

 Lobbying activity 1
Pharmacy

Advise and advocate on clients behalf regarding ongoing public policy concerns impacting the innovative biopharmaceutical industry in Congress and throughout the Administration.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem